PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.01%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.20%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.43%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.60%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.98%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.13%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.83%
Share reduction while OBE is at 0.12%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.69%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-5.60%
Dividend reduction while OBE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-28.42%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
101.88%
Positive 10Y revenue/share CAGR while OBE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
217.71%
5Y revenue/share CAGR above 1.5x OBE's 99.67%. David Dodd would look for consistent product or market expansions fueling outperformance.
98.77%
3Y revenue/share CAGR similar to OBE's 106.45%. Walter Schloss would assume both companies experience comparable short-term cycles.
-50.89%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
107.70%
5Y OCF/share CAGR above 1.5x OBE's 69.09%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
33.35%
3Y OCF/share CAGR under 50% of OBE's 236.91%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
155.59%
Net income/share CAGR 1.25-1.5x OBE's 138.69%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
210.93%
5Y net income/share CAGR 1.25-1.5x OBE's 160.44%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
734.12%
3Y net income/share CAGR above 1.5x OBE's 199.27%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-30.80%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-27.52%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-30.81%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-76.47%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
226.56%
Dividend/share CAGR of 226.56% while OBE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
158.99%
3Y dividend/share CAGR of 158.99% while OBE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-16.39%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
100.00%
Inventory growth of 100.00% while OBE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-3.68%
Negative asset growth while OBE invests at 1.52%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
14.62%
BV/share growth above 1.5x OBE's 4.53%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-7.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
9.78%
SG&A growth well above OBE's 14.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.